Is remote robotic subretinal injection feasible?
-
By
-
Andrea Surnit
-
September 2, 2026
-
3 min
By
Andrea Surnit
September 2, 2026
Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.
July 20, 2026
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.
May 11, 2026